Why The Drive For Medical Transition Should Be Re-Psychopathologized (#42)
9 October 2025
Global
Fifteen years after WPATH's 2010 campaign dismantled psychiatric oversight of gender medicine, Genspect has launched a counter-campaign calling for the re-psychopathologization of the drive toward medical transition. Stella O'Malley and Mia Hughes examine the diagnostic sequence — from DSM-5 to ICD-11 — that progressively removed clinical safeguards, and argue that compulsive pursuit of irreversible body modification meets criteria for pathological behaviour requiring mental health support. Their argument connects directly to systematic evidence reviews across Scandinavia and England that have since found the evidence base for paediatric gender medicine to be inadequate.
In October 2025, Genspect launched a formal campaign calling for the re-psychopathologization of the drive toward medical gender transition — a direct counter to the direction set by WPATH in 2010, codified in the DSM-5 in 2013 and extended by the WHO's ICD-11 in 2018. Hosts Stella O'Malley and Mia Hughes examine the reasoning behind that campaign and what the evidence suggests about the fifteen years that followed the original de-psychopathologization statement. The episode traces a specific historical sequence. In 2010, WPATH declared gender-variant identities to be natural and healthy and called for the removal of psychiatric diagnosis. The DSM-5 replaced "Gender Identity Disorder" with "Gender Dysphoria" in 2013, repositioning distress rather than identity as the clinical concern. In 2018, the WHO's ICD-11 went further, moving "Gender Incongruence" out of the mental health chapter entirely into a section on conditions related to sexual health. Each revision reduced the clinical oversight available to practitioners working with patients who sought medical intervention. O'Malley articulates a distinction central to Genspect's argument: a young person who explores a trans identity without pursuing irreversible physical interventions is not exhibiting pathological behaviour. It is the compulsive, escalating fixation on removing healthy organs and permanently dismantling the endocrine system that crosses a clinical threshold — the kind of presentation that, on any other complaint, would prompt comprehensive mental health assessment before surgical or hormonal referral. The campaign's position is not that trans identity itself constitutes a disorder, but that the drive toward irreversible body modification at that level of intensity meets criteria for pathological behaviour that warrants therapeutic support rather than medical facilitation. This framing draws on the concept of the "Extreme Overvalued Belief," a construct originating with nineteenth-century neurologist Carl Wernicke and revisited in contemporary forensic psychiatry. The concept describes a culturally reinforced, ego-syntonic belief that drives behaviour harmful to the individual — one addressed not by affirming the belief but by working with the psychological conditions underlying it. Applied to gender medicine, it offers a clinical vocabulary that distinguishes identity exploration from the compulsive drive toward self-modification. The episode connects directly to a pattern of independent conclusions reached across Europe. Systematic evidence reviews published in Sweden, Finland, Norway and Denmark between 2020 and 2024 restricted or substantially curtailed paediatric gender medicine, finding the evidence base for hormonal and surgical intervention in minors to be of low quality and long-term risks inadequately quantified. The Cass Review in England, published in 2024, reached parallel conclusions, linking the failure of clinical safeguards to the ideological environment that followed de-psychopathologization. These findings collectively suggest that the diagnostic architecture dismantled in 2010 served a gatekeeping function that was never replaced. For clinicians, regulators and courts operating under European frameworks, the episode raises a concrete question: if the diagnostic rationale for removing psychiatric oversight has been undermined by systematic review, what professional and legal obligations follow for institutions that adopted affirmation-only protocols in the intervening years? Re-psychopathologization is not merely a question of diagnostic classification; it bears directly on duty of care, informed consent, and the accountability of health systems for a decade of inadequately evaluated clinical practice.
